SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in FHTX — Foghorn Therapeutics Inc.
CIK 1446194
BALA CYNWYD, PA
Position in FHTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$55,624
-$130,726 QoQ
Shares Held
11,637
-70.6% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Derivatives in FHTX
reported options exposure · as of Jun 30, 2023CallValue
$211,904
CallShares
30,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in FHTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55,624 | 11,637 | Shares | Other | 2026-05-15 | |
| 2025-06-30 | $186,350 | 39,649 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $116,252 | 31,850 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $74,566 | 15,798 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $368,592 | 39,591 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $107,896 | 16,080 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $73,084 | 11,331 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $156,690 | 31,338 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $211,904 | 30,100 | Call | Defined | 2023-08-11 | |
| 2023-06-30 | $387,354 | 55,022 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $78,473 | 12,657 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $229,042 | 35,900 | Call | Defined | 2023-02-14 | |
| 2022-09-30 | $317,460 | 37,000 | Call | Defined | 2022-11-14 | |
| 2022-03-31 | $188,852 | 12,400 | Put | Defined | 2022-05-16 | |
| 2021-12-31 | $946,818 | 41,400 | Call | Defined | 2022-04-05 | |
| 2021-12-31 | $930,809 | 40,700 | Put | Defined | 2022-04-05 | |
| 2020-12-31 | $566,323 | 27,939 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||